Medicure Incorporated (TSXV: MPH, OTC: MCUJD.PK), a pharmaceutical company, announced yesterday that it has named Dr Neil Owens as its new President and Chief Operating Officer, effective 1 July 2019.
Owens will be responsible for implementing the company's strategic plans, and managing day-to-day operations, including the advancement and management of new and existing pharmaceutical products.
Owens has worked at Medicure since 2014, serving most recently as Director, Scientific Affairs. Owens holds a Bachelor of Science and a PhD in Chemistry from the University of Manitoba and has Post Doctoral experience with the IECB.
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
OncoHost receives BIG Innovation Award in Health category
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient